[{"innerBlocks":[],"name":"core\/freeform","postId":2019,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"There is a lack of clinical evidence supporting the efficacy of mobile healthcare interventions for improving the health outcomes of patients.

That\u2019s the contention of Ezekiel Emanuel, MD, who holds a joint position in the University of Pennsylvania\u2019s Wharton School of Business and the School of Medicine, where he chairs the Department of Medical Ethics & Health Policy.

\u201cThere\u2019s just not a single study that shows that any wearable, connectable smartphone, wireless (technology) has made a difference in terms of outcomes,\u201d Emanuel told Wednesday\u2019s opening session of the 2018 AHIP Institute & Expo in San Diego.

Also See:<\/b> NIH sets goal of evidence-based mHealth apps by 2020<\/a>

In his presentation, Emanuel took to task Eric Topol, MD, director of San Diego\u2019s Scripps Translational Science Institute and author of The Patient Will See You Now: The Future of Medicine is in Your Hands, for his contention that smartphones will serve to \u201cdemocratize healthcare,\u201d giving patients control of their health data, which has historically been the domain of physicians.

Emanuel mocked Topol as the \u201cguru for virtual medicine,\u201d and whose \u201chidden agenda is to forget the doctor\u201d and embrace smartphone-based medical dashboards that will help consumers track their own vital signs and overall health conditions, using that data for self-management of illness.

He pointed to a 2016 study<\/a> of remote patient monitoring of heart failure patients and a 2017 study<\/a> of medication adherence for patients with chronic disease\u2014both published in JAMA Internal Medicine\u2014that call into question the effectiveness of mobile healthcare interventions.

\u201cLots of studies\u2014over and over\u2014they come to the same conclusion,\u201d added Emanuel. \u201cThe wireless this, the pill bottle that\u2014not making a big difference.\u201d

However, Topol says Emanuel\u2019s contentions are patently false and ridiculous.

\u201cI had nothing to do with those studies (that Emanuel mentions), but he is off base to say there has not been an impact on outcomes,\u201d replied Topol in a written statement. \u201cYes, the results are mixed. But there are multiple studies that have shown improved outcomes for conditions such as managing blood pressure, preventing asthma attacks, diabetics with continuous glucose monitoring, and on and on. He just apparently picked the ones to support his bias and inappropriately quoted me beyond that.\u201d","saveContent":"There is a lack of clinical evidence supporting the efficacy of mobile healthcare interventions for improving the health outcomes of patients.

That\u2019s the contention of Ezekiel Emanuel, MD, who holds a joint position in the University of Pennsylvania\u2019s Wharton School of Business and the School of Medicine, where he chairs the Department of Medical Ethics & Health Policy.

\u201cThere\u2019s just not a single study that shows that any wearable, connectable smartphone, wireless (technology) has made a difference in terms of outcomes,\u201d Emanuel told Wednesday\u2019s opening session of the 2018 AHIP Institute & Expo in San Diego.

Also See:<\/b> NIH sets goal of evidence-based mHealth apps by 2020<\/a>

In his presentation, Emanuel took to task Eric Topol, MD, director of San Diego\u2019s Scripps Translational Science Institute and author of The Patient Will See You Now: The Future of Medicine is in Your Hands, for his contention that smartphones will serve to \u201cdemocratize healthcare,\u201d giving patients control of their health data, which has historically been the domain of physicians.

Emanuel mocked Topol as the \u201cguru for virtual medicine,\u201d and whose \u201chidden agenda is to forget the doctor\u201d and embrace smartphone-based medical dashboards that will help consumers track their own vital signs and overall health conditions, using that data for self-management of illness.

He pointed to a 2016 study<\/a> of remote patient monitoring of heart failure patients and a 2017 study<\/a> of medication adherence for patients with chronic disease\u2014both published in JAMA Internal Medicine\u2014that call into question the effectiveness of mobile healthcare interventions.

\u201cLots of studies\u2014over and over\u2014they come to the same conclusion,\u201d added Emanuel. \u201cThe wireless this, the pill bottle that\u2014not making a big difference.\u201d

However, Topol says Emanuel\u2019s contentions are patently false and ridiculous.

\u201cI had nothing to do with those studies (that Emanuel mentions), but he is off base to say there has not been an impact on outcomes,\u201d replied Topol in a written statement. \u201cYes, the results are mixed. But there are multiple studies that have shown improved outcomes for conditions such as managing blood pressure, preventing asthma attacks, diabetics with continuous glucose monitoring, and on and on. He just apparently picked the ones to support his bias and inappropriately quoted me beyond that.\u201d","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

AHIP keynoter cites lack of evidence that mHealth works

More for you